LYEL- Lyell Immunopharma, Inc.

Name: Lyell Immunopharma, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Lyell Immunopharma, Inc. (LYEL) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. LYEL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Shah Smital	140.0K	$2.71M	-
Dir	Klausner Richard	130.0K	$2.51M	-
Dir	Rieflin William Jl	130.0K	$2.51M	-
Dir	Brawley Otis W	130.0K	$2.51M	-
Dir	Friedman Cathy	130.0K	$2.51M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 11, 2026	Hill Stephen J.	Chief Operating Officer	Sell	1,236	$23.39	$28,910.04	-6.5%	-	-
Feb 11, 2026	Seely Lynn65	President And CEO	Sell	7,455	$23.39	$174,372.45	-9.1%	-	-
Feb 11, 2026	Lee Gary K.	Chief Scientific Officer	Sell	1,671	$23.39	$39,084.69	-9.0%	-	-
Feb 10, 2026	Bulis Veronica Sanchez50	VP, Corporate Controller	Sell	254	$23.12	$5,872.48	-1.6%	-	-
Feb 10, 2026	Lee Gary K.	Chief Scientific Officer	Sell	147	$23.12	$3,398.64	-0.8%	-	-
Feb 10, 2026	Seely Lynn65	President And CEO	Sell	438	$23.12	$10,126.56	-0.5%	-	-
Feb 10, 2026	Hill Stephen J.	Chief Operating Officer	Sell	109	$23.12	$2,520.08	-0.6%	-	-
Dec 30, 2025	Bulis Veronica Sanchez50	VP, Corporate Controller	Sell	2,072	$35.80	$74,180.64	-12.0%	-38.9%	-
Nov 10, 2025	Seely Lynn65	President And CEO	Sell	412	$16.11	$6,637.32	-0.6%	+31.5%	-
Nov 10, 2025	Bulis Veronica Sanchez50	VP, Corporate Controller	Sell	239	$16.10	$3,847.90	-2.5%	+31.5%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC